Literature DB >> 9375281

Cellular immune mechanisms in inflammatory myopathies.

R Hohlfeld1, A G Engel, N Goebels, L Behrens.   

Abstract

The inflammatory myopathies include dermatomyositis, polymyositis, and inclusion body myositis. In dermatomyositis, muscle fiber injury is secondary to an antibody- or immune-complex-mediated immune response against a vascular-endothelial component. In polymyositis and inclusion body myositis, CD8+ T cells and macrophages invade and eventually destroy initially nonnecrotic muscle fibers. The autoaggressive T cells have the phenotype of activated (HLA-DR+) memory (CD45RO+) cells. T-cell receptor analyses indicate that the autoaggressive T cells are oligoclonal. In inflammatory lesions, muscle fibers express various cytoplasmic and surface molecules that are not detectable in normal fibers. These molecules, which include HLA class I antigens, heat-shock proteins, adhesion molecules, and Fas, are probably induced by locally secreted cytokines. The autoaggressive CD8+ T cells harbor granules containing perforin that aggregate near the contact zone with the target muscle fiber. This is consistent with a perforin- and secretion-dependent mechanism of muscle fiber injury. Many invaded muscle fibers also express the Fas "death receptor," but signs of apoptosis are absent.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9375281     DOI: 10.1097/00002281-199711000-00007

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  23 in total

1.  B cells in autoimmunity.

Authors:  N A Mitchison; L R Wedderburn
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

2.  From black magic to science: understanding the rationale for the use of intravenous immunoglobulin to treat inflammatory myopathies.

Authors:  S Y Patel; D S Kumararatne
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

3.  Plasma cell-like morphology of Th1-cytokine-producing cells associated with the loss of CD3 expression.

Authors:  Guillaume Page; Arne Sattler; Sabine Kersten; Andreas Thiel; Andreas Radbruch; Pierre Miossec
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

4.  Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases.

Authors:  Stephan Seeliger; Thomas Vogl; Ingo Hubert Engels; J Michael Schröder; Clemens Sorg; Cord Sunderkötter; Johannes Roth
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

5.  Distinct inflammatory properties of late-activated macrophages in inflammatory myopathies.

Authors:  K M Rostasy; J Schmidt; E Bahn; T Pfander; M Piepkorn; E Wilichowski; J Schulz-Schaeffer
Journal:  Acta Myol       Date:  2008-10

Review 6.  Apoptosis of skeletal muscle cells and the pathogenesis of myositis: a perspective.

Authors:  C C Liu; J M Ahearn
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

7.  Interleukin-18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies.

Authors:  M Tucci; C Quatraro; F Dammacco; F Silvestris
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

8.  Sarcolemmal Complement Membrane Attack Complex Deposits During Acute Rejection of Myofibers in Nonhuman Primates.

Authors:  Daniel Skuk; Jacques P Tremblay
Journal:  J Neuropathol Exp Neurol       Date:  2019-01-01       Impact factor: 3.685

9.  Genetic risk and protective factors for the idiopathic inflammatory myopathies.

Authors:  Terrance P O'Hanlon; Frederick W Miller
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

10.  [Update: dermatomyositis].

Authors:  B Volc-Platzer
Journal:  Hautarzt       Date:  2010-01       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.